HomeCompareHEP vs MRK

HEP vs MRK: Dividend Comparison 2026

HEP yields 6.85% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.9K in total portfolio value
10 years
HEP
HEP
● Live price
6.85%
Share price
$20.45
Annual div
$1.40
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$0.71
Full HEP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HEP vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHEPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HEP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HEP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HEP
Annual income on $10K today (after 15% tax)
$581.91/yr
After 10yr DRIP, annual income (after tax)
$0.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,327.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HEP + MRK for your $10,000?

HEP: 50%MRK: 50%
100% MRK50/50100% HEP
Portfolio after 10yr
$38.8K
Annual income
$4,899.42/yr
Blended yield
12.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HEP
Analyst Ratings
4
Buy
4
Hold
4
Sell
Consensus: Buy
Price Target
$19.00
-7.1% upside vs current
Range: $19.00 — $19.00
Altman Z
1.1
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HEP buys
0
MRK buys
0
No recent congressional trades found for HEP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHEPMRK
Forward yield6.85%2.76%
Annual dividend / share$1.40$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.9K$56.8K
Annual income after 10y$0.71$9,798.13
Total dividends collected$698.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$19.00$128.54

Year-by-year: HEP vs MRK ($10,000, DRIP)

YearHEP PortfolioHEP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,042$342.30$11,206$366.19$164.00MRK
2$11,992$176.62$12,650$502.35$658.00MRK
3$12,921$89.63$14,407$694.19$1.5KMRK
4$13,871$45.13$16,585$967.82$2.7KMRK
5$14,864$22.64$19,342$1,363.89$4.5KMRK
6$15,916$11.34$22,913$1,947.19$7.0KMRK
7$17,036$5.67$27,662$2,823.89$10.6KMRK
8$18,231$2.84$34,159$4,173.35$15.9KMRK
9$19,509$1.42$43,337$6,308.80$23.8KMRK
10$20,875$0.71$56,776$9,798.13$35.9KMRK

HEP vs MRK: Complete Analysis 2026

HEPStock

Holly Energy Partners, L.P. provides petroleum product and crude oil transportation, terminalling, storage, and throughput services to the petroleum industry in the United States. It operates through two segments, Pipelines and Terminals, and Refinery Processing Unit. The company operates refined product pipelines that transport conventional gasolines, reformulated gasolines, and low-octane gasolines for oxygenate blending, as well as sulfur diesel and jet fuels, and liquefied petroleum gases; intermediate product pipelines that transport intermediate feedstocks and crude oils; and oil trunk, gathering, and connection pipelines that delivers crude oil. It operates 26 main pipelines; crude gathering networks; 10 refined product terminals; 1 crude terminal; 1 lube terminal; 31,800 track feet of rail storage; 7 locations with truck and/or rail racks; and tankages at 6 refining facility locations, as well as five refinery processing units. The company was incorporated in 2004 and is based in Dallas, Texas.

Full HEP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HEP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HEP vs SCHDHEP vs JEPIHEP vs OHEP vs KOHEP vs MAINHEP vs JNJHEP vs ABBVHEP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.